Corbus Pharmaceuticals Holdings (CRBP) Treasury Shares (2013 - 2023)
Corbus Pharmaceuticals Holdings (CRBP) posted quarterly Treasury Shares of $17911.0 for Q4 2023, down 26.17% quarter-over-quarter from $24259.0 in Q3 2023.
Corbus Pharmaceuticals Holdings (CRBP) Treasury Shares (2013 - 2023) Analysis & Trends
Corbus Pharmaceuticals Holdings' Treasury Shares history runs 2 years deep, the most recent figure standing at $17911.0 for Q4 2023.
- In Q4 2023, Treasury Shares changed N/A year-over-year to $17911.0; the TTM figure through Dec 2023 stood at $17911.0 (changed N/A YoY), while the FY2023 annual figure was $17911.0, changed N/A from the prior year.
- Treasury Shares for Q4 2023 stood at $17911.0, down from $24259.0 in the prior quarter.
- The five-year high for Treasury Shares was $24259.0 in Q3 2023, with the low at $17911.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 8.96 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 2.72 Mn |
| 10 | Corbus Pharmaceuticals Holdings | 127.63 Mn | -35.64 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 17,911.00 |
| Dec 31, 2023 | 17,911.00 |
| Sep 30, 2023 | 24,259.00 |
| Sep 30, 2023 | 24,259.00 |
| Jun 30, 2023 | 21,342.00 |
| Jun 30, 2023 | 21,342.00 |
| Mar 31, 2023 | 23,990.00 |
| Mar 31, 2023 | 23,990.00 |
| Dec 31, 2013 | 1.84 Mn |
| Dec 31, 2013 | 1.84 Mn |